Cara Therapeutics, Inc. (CARA)

Cara Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	52.18	64.15	13.45	32.09	18.71
Short-Term Investments	48.98	81.66	153.58	149.24	136.7
Cash & Cash Equivalents	101.17	145.81	167.04	181.33	155.41
Cash Growth	-30.62%	-12.71%	-7.88%	16.68%	-4.16%
Receivables	3.32	3.76	0.46	0.56	0.97
Inventory	2.82	2.38	2.58	0	0
Other Current Assets	8.85	16.96	3.22	13.18	9.27
Total Current Assets	116.16	168.91	173.29	195.07	165.66
Property, Plant & Equipment	8.19	1.98	3.6	5.12	3.74
Long-Term Investments	1.5	11.35	70.16	70.57	63.16
Other Long-Term Assets	0	0	0	0.41	0.41
Total Long-Term Assets	9.69	13.33	73.77	76.09	67.3
Total Assets	125.84	182.24	247.06	271.16	232.96
Accounts Payable	25.59	21.54	15.86	16.88	19.67
Deferred Revenue	0	0	0	0	22.26
Current Debt	0	1.92	1.76	1.6	0.97
Total Current Liabilities	25.59	23.46	17.62	18.48	42.89
Long-Term Debt	43.17	0	1.92	3.67	3.35
Total Long-Term Liabilities	43.17	0	1.92	3.67	3.35
Total Liabilities	68.76	23.46	19.53	22.16	46.25
Total Debt	43.17	1.92	3.67	5.28	4.32
Debt Growth	2150.63%	-47.78%	-30.37%	22.13%	-
Retained Earnings	-684.75	-566.23	-480.76	-392.32	-400.73
Comprehensive Income	-0.26	-1.67	-0.36	0.07	0.17
Shareholders' Equity	57.09	158.78	227.52	249	186.71
Net Cash / Debt	58	143.89	163.36	176.06	151.1
Net Cash / Debt Growth	-59.69%	-11.92%	-7.21%	16.52%	-6.82%
Net Cash Per Share	1.07	2.68	3.22	3.67	3.54
Working Capital	90.57	145.45	155.67	176.58	122.76
Book Value Per Share	1.05	2.96	4.49	5.25	4.38

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).